Levocarnitine and Aripiprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levocarnitine (levocarnitine) and Aripiprazole (aripiprazole). Common drug interactions include gastrointestinal disorder among females and chronic sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Levocarnitine and Aripiprazole. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

13 people who take Levocarnitine and Aripiprazole together, and have interactions are studied.

Levocarnitine and Aripiprazole drug interactions.

What are the common drug interactions of Levocarnitine and Aripiprazole, by gender? *:

female:

Gastrointestinal disorder (functional problems of gastrointestinal tract)
Infusion related reaction
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Vomiting
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Headache (pain in head)
Dyspnoea (difficult or laboured respiration)

male:

Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Drug ineffective
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Psychotic disorder
Sinusitis (inflammation of sinus)
Skin injury
Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other)
Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Levocarnitine and Aripiprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Vomiting
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Headache (pain in head)
Dyspnoea (difficult or laboured respiration)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Infusion related reaction

20-29:

n/a

30-39:

Drug ineffective
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Psychotic disorder
Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other)
Tremor (trembling or shaking movements in one or more parts of your body)

40-49:

Drug ineffective

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 9 people, 69.23%
Primary Immunodeficiency Syndrome: 4 people, 30.77%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 23.08%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 15.38%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 2 people, 15.38%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.69%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.69%
Psychotic Disorder: 1 person, 7.69%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
Biopsy Muscle Abnormal: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and Aripiprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously